• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2018PRICE SENSITIVE
AFT Maxigesic is now licensed in the Russian FederationPRICE SENSITIVE
AFT AFT Annual Meeting 2018 PresentationPRICE SENSITIVE
AFT Chairman's Address at AFT Annual MeetingPRICE SENSITIVE
AFT Annual ReportPRICE SENSITIVE
AFT Annual Report FY2018PRICE SENSITIVE
AFT AFT FY2018 Results AnnouncementPRICE SENSITIVE
AFT AFT Divests Non-Core Products to Focus on Key ProductsPRICE SENSITIVE
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2017PRICE SENSITIVE
AFT Results for announcement to the market App1PRICE SENSITIVE
AFT Interim Report FY2018PRICE SENSITIVE
AFT FY2018 H1 Update PresentationPRICE SENSITIVE
AFT 2017 Annual Meeting PresentationsPRICE SENSITIVE
AFT Issue of Annual Report to security holdersPRICE SENSITIVE
AFT Share Purchase Plan OpensPRICE SENSITIVE
AFT AFT FY2017 Results AnnouncementPRICE SENSITIVE
AFT Maxigesic now licensed in FrancePRICE SENSITIVE
AFT AFT Pharmaceuticals Presentation - Business UpdatePRICE SENSITIVE
AFT RPS SPP AnnouncementPRICE SENSITIVE
AFT Market UpdatePRICE SENSITIVE
AFT AFT Presentation FY2017 1H Year Update - amendedPRICE SENSITIVE
AFT AFT Half Year AnnouncementPRICE SENSITIVE
AFT AFT Half Year Announcement App IPRICE SENSITIVE
AFT AFT Pharmaceuticals Presentation FY2017 1H Year UpdatePRICE SENSITIVE
AFT AFT Interim Report H1 FY17PRICE SENSITIVE
AFT AFT Pharmaceuticals Limited – Market Trade Update FY2017 H1PRICE SENSITIVE
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2018
22/11/18PRICE SENSITIVE
AFT Maxigesic is now licensed in the Russian Federation
28/09/18PRICE SENSITIVE
AFT AFT Annual Meeting 2018 Presentation
03/08/18PRICE SENSITIVE
AFT Chairman's Address at AFT Annual Meeting
03/08/18PRICE SENSITIVE
AFT Annual Report
19/06/18PRICE SENSITIVE
AFT Annual Report FY2018
15/06/18PRICE SENSITIVE
AFT AFT FY2018 Results Announcement
23/05/18PRICE SENSITIVE
AFT AFT Divests Non-Core Products to Focus on Key Products
21/03/18PRICE SENSITIVE
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2017
23/11/17PRICE SENSITIVE
AFT Results for announcement to the market App1
23/11/17PRICE SENSITIVE
AFT Interim Report FY2018
23/11/17PRICE SENSITIVE
AFT FY2018 H1 Update Presentation
23/11/17PRICE SENSITIVE
AFT 2017 Annual Meeting Presentations
04/08/17PRICE SENSITIVE
AFT Issue of Annual Report to security holders
12/06/17PRICE SENSITIVE
AFT Share Purchase Plan Opens
24/05/17PRICE SENSITIVE
AFT AFT FY2017 Results Announcement
24/05/17PRICE SENSITIVE
AFT Maxigesic now licensed in France
22/05/17PRICE SENSITIVE
AFT AFT Pharmaceuticals Presentation - Business Update
17/03/17PRICE SENSITIVE
AFT RPS SPP Announcement
17/03/17PRICE SENSITIVE
AFT Market Update
17/02/17PRICE SENSITIVE
AFT AFT Presentation FY2017 1H Year Update - amended
25/11/16PRICE SENSITIVE
AFT AFT Half Year Announcement
24/11/16PRICE SENSITIVE
AFT AFT Half Year Announcement App I
24/11/16PRICE SENSITIVE
AFT AFT Pharmaceuticals Presentation FY2017 1H Year Update
24/11/16PRICE SENSITIVE
AFT AFT Interim Report H1 FY17
24/11/16PRICE SENSITIVE
AFT AFT Pharmaceuticals Limited – Market Trade Update FY2017 H1
11/11/16PRICE SENSITIVE
(20min delay)
Last
$2.71
Change
0.060(2.26%)
Mkt cap ! n/a
Open High Low Value Volume
$2.65 $2.72 $2.65 $400.7K 148.5K

Buyers (Bids)

No. Vol. Price($)
0 2 $2.71
 

Sellers (Offers)

Price($) Vol. No.
$2.84 4000 0
Last trade - 13.00pm 22/11/2024 (20 minute delay) ?
AFT (NZSX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.